no enhanced bioavailability vs epidylix though.....
so the animal studies didnt translate.
not the homerun we were looking for.
animal studies showed 1.5 -2 x bioavailability.
now we are highlighting its better than other australian products.. but no better in bioavilibility than market leader.
So whats our advantage? cheaper, easier dosing, capsule vs oil, preference from consumer? its not more effective dose for dose
- Forums
- ASX - By Stock
- EMD
- Ann: EMD-RX5 demonstrates excellent safety and bioavailability
Ann: EMD-RX5 demonstrates excellent safety and bioavailability, page-4
-
- There are more pages in this discussion • 91 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMD (ASX) to my watchlist
|
|||||
Last
3.2¢ |
Change
-0.002(5.88%) |
Mkt cap ! $13.08M |
Open | High | Low | Value | Volume |
3.3¢ | 3.3¢ | 3.2¢ | $4.478K | 137.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 87722 | 3.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.5¢ | 48000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 87722 | 0.032 |
1 | 32258 | 0.031 |
5 | 91251 | 0.030 |
1 | 103482 | 0.029 |
2 | 50000 | 0.028 |
Price($) | Vol. | No. |
---|---|---|
0.035 | 48000 | 2 |
0.037 | 70000 | 1 |
0.039 | 120000 | 2 |
0.040 | 135180 | 1 |
0.045 | 66878 | 1 |
Last trade - 15.57pm 23/08/2024 (20 minute delay) ? |
EMD (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online